$1M grant will help researchers develop “smart insulin” as a safer option for type 1 diabetes
Thursday, March 14, 2013
Thanks to a new three-year, $1 million grant, a group of researchers at Case Western Reserve University are continuing to develop and test a form of glucose-responsive insulin that may someday be able to reduce the risk of dangerous hypoglycemic episodes in people with type 1 diabetes.
Big Market, Bigger Mission
Tuesday, January 25, 2011
In an interview with JumpStart, Richard Berenson, CEO of Thermalin Diabetes, talked about how his company's success could change the lives of millions and put him in a position to help other entrepreneurs. Read Richard's story.